HCC
CL icon

Hirtle Callaghan & Co’s Colgate-Palmolive CL Stock Holding History

Hirtle Callaghan & Co’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,800
Closed -$223K – 97
2023
Q4 		$223K Buy
+2,800
New +$211K 0.01% 87
2022
Q3 		– Sell
-2,629
Closed -$211K – 108
2022
Q2 		$211K Sell
2,629
-972
-27% -$76K 0.01% 121
2022
Q1 		$273K Buy
+3,601
New +$285K 0.01% 115
2015
Q1 		– Sell
-31,336
Closed -$2.17M – 77
2014
Q4 		$2.17M Buy
31,336
+30
+0.1% +$2.03K 0.5% 36
2014
Q3 		$2.04M Sell
31,306
-8
-0% -$528 0.34% 47
2014
Q2 		$2.13M Buy
31,314
+8
+0% +$536 0.3% 51
2014
Q1 		$2.03M Hold
31,306
– – 0.34% 47
2013
Q4 		$2.04M Buy
31,306
+8,158
+35% +$522K 0.27% 48
2013
Q3 		$1.37M Buy
+23,148
New +$1.37M 0.22% 61

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hirtle Callaghan & Co's CL Position: Q1 2024 in Review

Hirtle Callaghan & Co sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 2,800 shares — an estimated $223K sold.

Hirtle Callaghan & Co first reported a position in CL in Q3 2013 and held it in 9 quarters. The position peaked at $2.17M in Q4 2014. 1,767 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Hirtle Callaghan & Co reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,800 Colgate-Palmolive shares in Q1 2024, an estimated $223K.
  • Hirtle Callaghan & Co first reported a position in Colgate-Palmolive in Q3 2013 and held it in 9 quarters.
  • Hirtle Callaghan & Co's Colgate-Palmolive position peaked at $2.17M in Q4 2014.
  • 1,767 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2024, filed 10 May 2024.